The medical black technology system of the top student

Before you know it, the day is approaching the start of school.

During this time, Lu Liang has been reading literature related to chronic myelogenous leukemia.

Compared with review, the new knowledge learned from the literature allows Lu Liang to gain more experience from the system.

After a summer vacation, Lu Liang's level was naturally upgraded from lv1 to lv2.

Even the experience bar of level 2 is already over half, and it won't take long to break through to level 3.

This also means that the next time Lu Liang analyzes a new drug, he will be able to obtain two different drug synthesis routes at the same time.

Lu Liang is quite satisfied with the speed of experience accumulation and level improvement.

However, the only fly in the ointment is the accumulation of source points.

So far, the number of source points has increased from the initial 0.05 source points to 0.22 source points.

Although it has exceeded the 0.1 mark, there is still a long way to go before reaching 1 source point.

Looking at the source points slowly accumulating in the system, Lu Liang couldn't help but sigh.

He originally thought about whether he could accumulate a complete source point through these two months of study.

Now it seems that he was out of his mind.

Obtaining source points is different from obtaining experience. It is much more difficult than Lu Liang imagined.

If you want to obtain a source point by relying on learning, you will probably have to learn for years and months to succeed.

It seems that you want to get the most source points in the shortest time.

The only way is to rely on drug sales.

Lu Liangliang began to think about it.

Unfortunately, the second-generation drugs are still in the clinical trial stage, and we don’t know how long it will take for the results to be available.

Just when Lu Liang felt that there was nothing he could do, the door of the study room was suddenly pushed open.

Ji Hong walked into the study room. His eyes bypassed other positions and fell directly on Lu Liang.

"Xiao Lu, come here with me."

Ji Hongchong waved to Lu Liang.

Lu Liang put down what he was holding and followed Ji Hong into the office.

"Close the door."

Ji Hong reminded him with a mysterious look.

This made Lu Liang a little confused, why should it be kept so secret?

However, Lu Liang still closed the office door tightly as Ji Hong said.

After doing all this, Lu Liang looked at Ji Hong and asked, "Teacher Ji, what do you want from me?"

Ji Hong took a deep breath, then mysteriously took out a stack of reports from his briefcase and placed it on the table.

When he saw this stack of reports, Lu Liang seemed to realize something, and his eyes suddenly lit up.

And what Ji Hong said next directly verified what Lu Liangzhong had guessed.

"Xiao Lu, the clinical trial results of your second-generation drug are out."

Ji Hong pushed the test results report in front of Lu Liang, and then said with a smile: "Xiao Lu, do you want to see the results?"

In fact, Lu Liang could guess the test results without even looking.

After all, previous generations have conducted countless trials on the second-generation drug dasatinib, and there is a lot of reliable data.

If second-generation drugs fail to pass phase III clinical trials, then something is wrong.

However, just in case, Lu Liang still took the report and glanced at it.

The report shows that compared with the control group, the number of white blood cells in the blood of patients in the different dose test groups was significantly reduced, and the phosphorylation of tyrosine protein kinase in the cells was significantly inhibited.

This means that second-generation drugs have extremely obvious therapeutic effects on chronic myelogenous leukemia.

After seeing it with his own eyes, Lu Liangliang was still excited, and he couldn't help but grin.

This news was like a timely rain for him.

Originally, he was still worried about the slow progress in obtaining source points.

Now that the third-phase clinical trial of the second-generation drug has passed, when the drug is produced and launched, he will be able to obtain enough sources just by selling the drug.

Seeing the excited look on Lu Liang's face, Ji Hong couldn't help but laugh.

In fact, when he just got the test report, his reaction was even more exaggerated than Lu Liang's.

He never imagined that the second-generation drug provided by Lu Liang could pass the third phase of clinical trials so smoothly.

This feeling is like a dream.

Of course, in addition to the sense of dream, Ji Hong felt more proud and proud.

Although the drug was not discovered by his research, it was screened by Lu Liang.

But Lu Liang is his student, the student he brought out.

As Lu Liang's mentor, how could he not be proud of his student?

Ji Hong continued: "Judging from the results of clinical trials, the second-generation drugs are very effective and have successfully passed the third phase of clinical trials. The drug's patent application and Food and Drug Administration approval are already in the process. If it’s unexpected, it will come down in the next two days.”

"As soon as the drug license comes out, the drug will be produced immediately!"

After hearing the news, Lu Liang's spirits were lifted.

If you are an ordinary person, you may have to wait for a while for the approval process, but as Ji Hongdu said, there must be a way to speed up the approval process.

In this regard, Lu Liang naturally hopes that the sooner the better.

"Xiao Lu, how did you do it...how did you screen out the compound." Ji Hong coughed and mentioned this old problem again.

Ji Hong didn't delve into this matter before because he didn't have high expectations for this second-generation drug.

It’s different now. Now the second-generation drugs have successfully passed phase III clinical trials.

Ji Hong naturally became curious.

Lu Liang said with a smile: "Teacher Ji, didn't I tell you everything last time? I found it in the book."

"Okay, okay, I know. If you don't tell me, I won't force you."

Ji Hong smiled and shook his head. It was naturally impossible for him to believe Lu Liang's statement.

Ji Hong also noticed that Lu Liang didn't seem to want to say more in this regard, so he simply didn't bother to ask again.

After all, as long as the result is good, it doesn’t matter what the process is.

However, there was one more thing that surprised Lu Liang. He asked, "Teacher Ji, why did the results of the clinical trial come out so quickly?"

Lu Liangliang knew very well that it would take a long time for the results of Phase III clinical trials to be available.

According to Lu Liang's estimation, if the process is followed normally, it will take a few months at the earliest to get the results.

Ji Hongping calmed down and replied with a smile: "There are domestic policies that allow fast-track access to innovative drugs that can save patients' lives, and"

When he said this, Ji Hong paused, and a mysterious smile appeared on his face: "Do you really think of me as your teacher? I don't have many friends outside to help?"

After hearing what Ji Hong said, Lu Liang suddenly had a look of surprise on his face.

No wonder the results of the Phase III clinical trial came out so quickly.

ps: The normal phase III clinical drug trial cycle is 3-4 years.